CPhi Preview 2013: Ashland
2013 CPhI Exhibitor Preview
Company: Ashland Inc.
Description: Ashland Specialty Ingredients offers an unparalleled range of cellulosic and vinyl pyrrolidone polymers to meet the needs of pharmaceutical and nutraceutical formulators. Ashland is the full-service solid-dosage resource for tablet binding, film coating and disintegration; as well as excipients for controlled release and drug solubilization. To learn more, visit ashland.com/pt/pharmaceutical.
Website: ashland.com/pt/pharmaceutical
Booth Number: Hall 6.1, Booth 61B38
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
